If you need more lookups,
subscriptions start at $34 USD/month.
Mark Zhang Location
Boston, MA, US
Mark Zhang Work
Senior Director, Head of Global Program Management Oncology II @ (February 2021 - Present)
Senior Director, Head of Project Management Avelumab Program @ (July 2019 - December 2023)
Head of Strategy and Business Operations China R and D @ (April 2013 - July 2019)
Head of Clinical Operations China ad-interim @ (January 2018 - October 2018)
Deputy Head of China R and D @ (October 2016 - January 2018)
Associate Director, Project and Portfolio Management at Beijing R and D Hub @ (October 2012 - April 2013)
Associate Director, Global Development Asia Portfolio Operations @ (March 2012 - October 2012)
Senior Global Feasibility Strategist @ (May 2011 - March 2012)
Head, Global Clinical Program and Study Management-Oncology(UK and APAC) @ (September 2010 - May 2011)
Manager of Study Management @ (June 2008 - August 2010)
Study Manager @ (July 2006 - June 2008)
CRA, SCRA, Project Leader, Global Clinical Operations @ (December 2000 - July 2006)
Mark Zhang Education
BiMBA at Peking University
Master of Business Administration - MBA
2016-2018
Vlerick Business School
Master of Business Administration - MBA
2016-2018
Chengdu University of Traditional Chinese Medicine
(Medicine)
1990-1995
Project Management Institute
PMP
Mark Zhang Skills
Biotechnology
Clinical Trials
Lifesciences
Management
Oncology
Pharmaceutical Industry
Regulatory Affairs
Mark Zhang Summary
Mark Zhang, based in Boston, MA, US, is currently a Senior Director, Head of Global Program Management Oncology II at EMD Serono, Inc.. Mark Zhang brings experience from previous roles at EMD Serono, Inc. and Merck Healthcare. Mark Zhang holds a 2016 - 2018 Master of Business Administration - MBA @ BiMBA at Peking University. With a robust skill set that includes Biotechnology, Clinical Trials, Lifesciences, Management, Oncology and more. Mark Zhang has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Mark Zhang?
Find contact details for 700 million professionals.